(Q43583632)

24 November 2017

title

Co-administration of memantine and amantadine with sub/suprathreshold doses of L-Dopa restores motor behaviour of MPTP-treated mice (English)

1 reference

24 November 2017

2

W Danysz

1 reference

24 November 2017

A Fredriksson

1

1 reference

24 November 2017

G Quack

series ordinal

3

1 reference

24 November 2017

T Archer

series ordinal

4

1 reference

24 November 2017

language of work or name

1 reference

1 January 2001

1 reference

Journal of Neural Transmission

24 November 2017

published in

1 reference

24 November 2017

volume

108

1 reference

24 November 2017

issue

2

1 reference

24 November 2017

page(s)

167-187

1 reference

https://scigraph.springernature.com/pub.10.1007/s007020170086

24 November 2017

exact match

0 references

cites work

Modulation of levodopa-induced motor response complications by NMDA antagonists in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS007020170086

Wearing-off fluctuations in Parkinson's disease: contribution of postsynaptic mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007020170086

Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007020170086

Are NMDA antagonistic properties relevant for antiparkinsonian-like activity in rats?--case of amantadine and memantine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007020170086

Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents--preclinical studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007020170086

Differential effects of NMDA and non-NMDA antagonists on the activity of aromatic L-amino acid decarboxylase activity in the nigrostriatal dopamine pathway of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007020170086

MPTP-induced hypoactivity in mice: reversal by L-dopa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007020170086

Motor responses to dopamine D1 and D2 agonists in the reserpine-treated mouse are affected differentially by the NMDA receptor antagonist MK 801

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007020170086

Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007020170086

Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007020170086

L-dopa in Parkinsonism and the influence of previous thalamotomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007020170086

NMDA antagonists potentiate antiparkinsonian actions of L-dopa in monoamine-depleted rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007020170086

Dopamine/glutamate interactions in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007020170086

Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: effect of dopaminergic denervation and L-DOPA administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007020170086

Neuroprotective properties of the uncompetitive NMDA receptor antagonist remacemide hydrochloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007020170086

Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007020170086

Comparative patch-clamp studies with freshly dissociated rat hippocampal and striatal neurons on the NMDA receptor antagonistic effects of amantadine and memantine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007020170086

Efficacy of memantine, an NMDA receptor antagonist, in the treatment of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007020170086

Behavioural pharmacology of glutamate receptors in the basal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007020170086

The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007020170086

Further Studies on the Mode of Action of Amantadine

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS007020170086

21 January 2018

12 December 2020

Chronic neurochemical and behavioral changes in MPTP-lesioned C57BL/6 mice: a model for Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS007020170086

Dextromethorphan improves levodopa-induced dyskinesias in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007020170086

Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007020170086

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007020170086

Effect of amantadine on some psychomotor performances in Parkinsonism. A double blind study

21 January 2018

1 reference

12 December 2020

[Amantadine therapy in parkinsonism]

1 reference

12 December 2020

Synergistic interactions between NMDA-antagonists and L-dopa on activity in MPTP-treated mice

1 reference

12 December 2020

Effects of co-administration of anticonvulsant and putative anticonvulsive agents and sub/suprathreshold doses of L-dopa upon motor behaviour of MPTP-treated mice

1 reference

12 December 2020

Dopamine agonists potentiate antiakinetic effects of competitive NMDA-antagonists in monoamine-depleted mice

1 reference

12 December 2020

Effect of the competitive NMDA antagonist, CGP 40 116, and a low dose of l-Dopa on the motor activity deficit of MPTP-treated mice

1 reference

12 December 2020

Amantadine and motor fluctuations in chronic Parkinson's disease

1 reference

12 December 2020

Opposite effects of NMDA receptor blockade on dopaminergic D1- and D2-mediated behavior in the 6-hydroxydopamine model of turning: relationship with c-fos expression

1 reference

12 December 2020

MPTP neurotoxicity: an overview and characterization of phases of toxicity

1 reference

12 December 2020

NMDA receptor blockade reverses motor response alterations induced by levodopa

1 reference

12 December 2020

Some central effects of CGP 37849 and CGP 39551, the competitive NMDA receptor antagonists: potential antiparkinsonian activity

1 reference

12 December 2020

Reversal of levodopa-induced motor fluctuations in experimental parkinsonism by NMDA receptor blockade

1 reference

12 December 2020

Amantadine attenuates response alterations resulting from repetitive L-DOPA treatment in rats

1 reference

12 December 2020

MPTP-induced behavioural and biochemical deficits: a parametric analysis

1 reference

12 December 2020

Dissociation between biochemical and behavioral recovery in MPTP-treated mice

1 reference

12 December 2020

Effect of coadministration of glutamate receptor antagonists and dopaminergic agonists on locomotion in monoamine-depleted rats

1 reference

12 December 2020

Derivatives of cis-2-amino-8-hydroxy-1-methyltetralin: mixed 5-HT1A-receptor agonists and dopamine D2-receptor antagonists

1 reference

12 December 2020

Tolerance to a suprathreshold dose of L-Dopa in MPTP mice: effects of glutamate antagonists

1 reference

12 December 2020

Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties.

1 reference

12 December 2020

Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects

1 reference

12 December 2020

Synergistic interactions between the NMDA antagonist dizocilpine and the preferential dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 with regard to locomotor stimulation in monoamine-depleted mice

1 reference

12 December 2020

Memantine, amantadine, and L-deprenyl potentiate the action of L-dopa in monoamine-depleted rats

1 reference

12 December 2020

Identifiers

DOI

10.1007/S007020170086

1 reference

Dimensions Publication ID

24 November 2017

1016865872

0 references

1 reference